The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
CHFR Methylation Status Esophageal Cancer Study
- Conditions
- Esophageal Cancer
- Interventions
- Radiation: RadiotherapyProcedure: Esophagectomy
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2019-01-25
- Target Recruit Count
- 31
- Registration Number
- NCT01372202
- Locations
- 🇺🇸
Ronan Kelly, M.D., Baltimore, Maryland, United States
Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer
- Conditions
- Suspected Primary Prostate Cancer
- Interventions
- Device: ProxiScan (scintigraphic rectal probe)
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2016-09-02
- Target Recruit Count
- 4
- Registration Number
- NCT01359189
- Locations
- 🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2019-01-15
- Target Recruit Count
- 19
- Registration Number
- NCT01349569
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
- Conditions
- Multiple MyelomaLeukemiaHodgkin's LymphomaMyelodysplastic Syndrome(MDS)Non Hodgkin's Lymphoma
- Interventions
- Radiation: Total body irradiationBiological: Bone marrow transplant
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2018-10-17
- Target Recruit Count
- 127
- Registration Number
- NCT01342289
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Drug: Muscadine Plus Grape Skin ExtractDrug: Placebo oral capsuleDrug: Low-dose MPXDrug: High-dose MPX
- First Posted Date
- 2011-03-17
- Last Posted Date
- 2021-04-02
- Target Recruit Count
- 143
- Registration Number
- NCT01317199
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2011-02-15
- Last Posted Date
- 2016-03-22
- Target Recruit Count
- 18
- Registration Number
- NCT01296763
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2018-11-27
- Target Recruit Count
- 10
- Registration Number
- NCT01293539
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
- Conditions
- Transplant-Related Cancer
- Interventions
- Biological: HavrixBiological: PCV13
- First Posted Date
- 2011-01-24
- Last Posted Date
- 2019-05-30
- Target Recruit Count
- 120
- Registration Number
- NCT01282216
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Radiation: High-dose endorectal brachytherapy (HDRBT)
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2025-02-28
- Target Recruit Count
- 16
- Registration Number
- NCT01226979
- Locations
- 🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
- Conditions
- Hematologic Malignancies
- Interventions
- Radiation: Total Body IrradiationProcedure: Allogeneic Blood or Marrow TransplantProcedure: Peripheral Blood Stem Cell Transplant
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 89
- Registration Number
- NCT01203722
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States